These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21812876)

  • 1. Characterization of the staphylococcal bacteriophage lysin CHAP(K).
    Fenton M; Ross RP; McAuliffe O; O'Mahony J; Coffey A
    J Appl Microbiol; 2011 Oct; 111(4):1025-35. PubMed ID: 21812876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells.
    Becker SC; Dong S; Baker JR; Foster-Frey J; Pritchard DG; Donovan DM
    FEMS Microbiol Lett; 2009 May; 294(1):52-60. PubMed ID: 19493008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
    Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
    Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice.
    Fenton M; Casey PG; Hill C; Gahan CG; Ross RP; McAuliffe O; O'Mahony J; Maher F; Coffey A
    Bioeng Bugs; 2010; 1(6):404-7. PubMed ID: 21468207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined antibacterial activity of phage lytic proteins holin and lysin from Streptococcus suis bacteriophage SMP.
    Shi Y; Li N; Yan Y; Wang H; Li Y; Lu C; Sun J
    Curr Microbiol; 2012 Jul; 65(1):28-34. PubMed ID: 22526567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan.
    Sundarrajan S; Raghupatil J; Vipra A; Narasimhaswamy N; Saravanan S; Appaiah C; Poonacha N; Desai S; Nair S; Bhatt RN; Roy P; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S; Sharma U
    Microbiology (Reading); 2014 Oct; 160(Pt 10):2157-2169. PubMed ID: 25023246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin.
    Gu J; Feng Y; Feng X; Sun C; Lei L; Ding W; Niu F; Jiao L; Yang M; Li Y; Liu X; Song J; Cui Z; Han D; Du C; Yang Y; Ouyang S; Liu ZJ; Han W
    PLoS Pathog; 2014 May; 10(5):e1004109. PubMed ID: 24831957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Lytic Activity of Phage-Derived Peptidoglycan Hydrolase, LysSAP8, as a Potent Alternative Biocontrol Agent for
    Yu JH; Lim JA; Chang HJ; Park JH
    J Microbiol Biotechnol; 2019 Dec; 29(12):1916-1924. PubMed ID: 31635440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.
    Obeso JM; Martínez B; Rodríguez A; García P
    Int J Food Microbiol; 2008 Dec; 128(2):212-8. PubMed ID: 18809219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic activity of the staphylolytic Twort phage endolysin CHAP domain is enhanced by the SH3b cell wall binding domain.
    Becker SC; Swift S; Korobova O; Schischkova N; Kopylov P; Donovan DM; Abaev I
    FEMS Microbiol Lett; 2015 Jan; 362(1):1-8. PubMed ID: 25790497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein.
    Paul VD; Rajagopalan SS; Sundarrajan S; George SE; Asrani JY; Pillai R; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S
    BMC Microbiol; 2011 Oct; 11():226. PubMed ID: 21985151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.
    O'Flaherty S; Coffey A; Meaney W; Fitzgerald GF; Ross RP
    J Bacteriol; 2005 Oct; 187(20):7161-4. PubMed ID: 16199588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88.
    Rodríguez L; Martínez B; Zhou Y; Rodríguez A; Donovan DM; García P
    BMC Microbiol; 2011 Jun; 11():138. PubMed ID: 21682850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils.
    Chang Y; Kim M; Ryu S
    Food Microbiol; 2017 Dec; 68():112-120. PubMed ID: 28800818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus.
    Keary R; Sanz-Gaitero M; van Raaij MJ; O'Mahony J; Fenton M; McAuliffe O; Hill C; Ross RP; Coffey A
    Curr Protein Pept Sci; 2016; 17(2):183-90. PubMed ID: 26521950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chimeric LysK-Lysostaphin Fusion Enzyme Lysing Staphylococcus aureus Cells: a Study of Both Kinetics of Inactivation and Specifics of Interaction with Anionic Polymers.
    Filatova LY; Donovan DM; Ishnazarova NT; Foster-Frey JA; Becker SC; Pugachev VG; Balabushevich NG; Dmitrieva NF; Klyachko NL
    Appl Biochem Biotechnol; 2016 Oct; 180(3):544-557. PubMed ID: 27168405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage phi11 lysin: Physicochemical characterization and comparison with phage phi80α lysin.
    Filatova LY; Donovan DM; Foster-Frey J; Pugachev VG; Dmitrieva NF; Chubar TA; Klyachko NL; Kabanov AV
    Enzyme Microb Technol; 2015 Jun; 73-74():51-8. PubMed ID: 26002504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP; Lang S; Gemmell CG; Coote PJ
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.
    Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
    Virol J; 2014 Jul; 11():133. PubMed ID: 25064136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.